Clinical trial Recruiting at 1 site Observational Ages 3 and up

Validation of a questionnaire to screen children for visual disorders

Official title: Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders

Run by Université Catholique de Louvain · NCT06997354 · Data updated 2026-11-12

This study is testing a new questionnaire to help find out if children aged 3 to 12 have visual problems caused by brain issues, especially for French-speaking families.

Quick facts

Study typeObservational
Ages3 Years and up
SexAll
Enrollment250 (estimated)
SponsorUniversité Catholique de Louvain
Academic / other
Locations1 site (Louvain-la-Neuve)
StatusRecruiting
StartedApril 1, 2025
Main results expectedJune 15, 2025
Study endsJune 15, 2026
Registry record updatedMay 30, 2025
Trial IDNCT06997354 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are parents of children aged 3 to 12 who are French speakers and have concerns about their child's visual development.

Probably not a fit

Patients who do not have children within the specified age range or who do not speak French may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate a questionnaire designed to screen children for cortical visual impairment (CVI), a condition where visual difficulties arise from brain damage rather than eye damage. The research focuses on children aged 3 to 12, particularly those whose parents are French speakers, to ensure accurate understanding of the questionnaire. By identifying children with CVI, the study seeks to improve diagnosis and care for this often-overlooked condition, which affects a significant percentage of young children. The study will involve both a clinical group of children showing signs of CVI and a control group without developmental issues.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and tailored interventions for children suffering from cortical visual impairment.

How similar studies have gone: While there is limited information on similar studies, the validation of screening tools for specific conditions like CVI is a recognized need, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parents of a child aged between 3 and 12
* Their mother tongue must be French, to ensure that they understand the questions asked in writing.

Control group:

\- Children of the parents surveyed who do not present any medical, school or family developmental particularities.

Clinical group

\- Children of the parents interviewed who present warning signs of CVI reported by a multidisciplinary team specialized in visual impairment.

Exclusion Criteria:

* no specific criteria (see inclusion criteria)

Where it's running

  • 10 place cardinal Mercier
    Louvain-la-Neuve, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.